Search
Close this search box.
Logo Asphalion

WEBINAR | US INVESTIGATIONAL NEW DRUG (IND) APPLICATIONS

Free webinar on US Investigational New Drug (IND) Applications.

Free webinar on US Investigational New Drug (IND) Applications.
June 18, 2021

SAVE THE DATE!!

Free webinar on US Investigational New Drug (IND) Applications. The experts, Bruce Thompson from WR Regulatory Services, as well as Vicente Tur and Michael Schaub from ASPHALION will discuss about the following:

  • Pre-IND and IND fundamentals; US agent requirements
  • IMPD to IND conversion – going from EU to the US
  • IND eCTD publishing and submission
  • Q&A

📆 When? July 7th, 2021

🕗 Time: 3:00- 4:00 p.m. (CEST)

✑ You can register here:

https://register.gotowebinar.com/register/6371045776036807183

Should you have any questions, you can contact us at: info@asphalion.com

 

Search News & Events

  • Filter by category

Share

Related news and events

IZABELA BEDZIAK | NEW ASSOCIATE DIRECTOR

At Asphalion we are proud to announce that Izabela Bedziak is now Scientific & Regulatory Affairs Associate Director!! Izabela has a BC and a Master’s Degree in Pharmacy from

CTIS applicable | Faster Access to Clinical Trial Information in Europe

CTIS is the single-entry point for the submission and assessment of clinical trial applications in the EU. It features a public, searchable database aimed at delivering a high level of transparency. The authorisation and oversight of clinical trials are managed by EU/EEA Member States, while the EMA maintains the CTIS. The European Commission oversees the implementation of the Clinical Trials Regulation.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting